Uredba O Nacionalnom Programu Prevencije, Lečenja I Kontrole Kardiovaskularnih Bolesti Do 2020. Godine

Objectives

The National Programme for the Prevention, Treatment and Control of Cardiovascular Diseases in the Republic of Serbia, running to 2020, aims to reduce cardiovascular morbidity and mortality, improve quality of life, and reduce health inequalities by addressing risk factors, wider determinants of health and health-system capacity.[1]Its overarching objectives are to prevent risk factors, enable early identification and diagnosis, improve treatment, reduce disability and complications, and support people living with cardiovascular disease.[2]

• Strengthen population and individual prevention through health promotion, screening, early detection, protective environments and action on social and economic determinants of health.[1][3]
• Reduce hypertension through a 5% decrease in affected people, a 10% increase in newly detected cases through better diagnosis, and a 10% reduction in complications.[4]
• Reduce dyslipidaemia by 2% annually, improve access to treatment, and develop guidance for hyperlipoproteinaemia.[5]
• Prevent obesity and diabetes, promote healthy nutrition and physical activity, and reduce tobacco use through cessation support, tobacco controls, health warnings and sustained pricing measures.[5][6][7][8]
• Prevent, diagnose and manage congenital heart defects, acute coronary syndrome, heart failure, arrhythmias, atherosclerotic vascular disease and cardiovascular conditions requiring interventional cardiology or surgery.[9][10][11][12][13][14]
• Improve rehabilitation, functional recovery and secondary prevention following acute cardiovascular illness and surgery.[15]
• Build cardiovascular research, prospective registers and participation in international initiatives, including “Stent for Life” and stem-cell research projects.[16][17]

Implementation

The programme adopts an integrated, multisectoral delivery model combining population-wide prevention with individual clinical care across primary, secondary and tertiary services.[1][3]It links health promotion, legislation and financing, workforce and infrastructure, community support, information systems, clinical standards, research and monitoring.[2]Implementation is financed from the Republic of Serbia budget under the Ministry of Health allocation, subject to budgetary capacity, and through resources planned in the financial plan of the Republican Health Insurance Fund; no monetary allocations or detailed costings are specified.[17]

• Deliver prevention through public education, healthier living and working conditions, food labelling and food-quality measures, tobacco control, physical-activity promotion, and systematic management of environmental risks such as urban noise.[18][19][4][20][7][21]
• Provide regular blood-pressure screening for children aged three to 18 and adults in primary healthcare every two years, alongside risk screening for obesity, dyslipidaemia, hypertension and type 2 diabetes during routine examinations.[4][21]
• Assign selected doctors to deliver screening and designate one doctor in each health centre to coordinate the programme.[20]
• Develop national health information systems, population research, cardiovascular disease registers and legal protections for privacy, confidentiality and information security.[18]
• Strengthen emergency and acute-care pathways through staff training, coordinated referral systems, standardised prehospital equipment, telecommunications links with hospitals, coronary-unit standards and increased use of reperfusion treatment.[22][11]
• Expand specialist capacity through catheterisation laboratories, primary angioplasty centres, arrhythmia and pacemaker services, telemedicine monitoring, automated external defibrillators, vascular surgery, cardiac surgery and specialised tertiary units for adults with congenital heart disease.[10][12][23][13][24]
• Provide rehabilitation from hospital departments through day hospitals and specialised institutions, supported by patient education, follow-up databases and continuous professional development.[15]
• Coordinate delivery among the Ministry of Health, Republic Health Insurance Fund, Institute of Public Health of Serbia and its network, health centres, hospitals, clinics, medical faculties, professional associations, local government, statistical bodies, communities and relevant non-governmental partners.[8][15][17]
• Monitor implementation through health-statistical data, programme indicators, registers, direct field insight and continuous six-monthly reports from relevant primary-care, hospital and public-health bodies to the Institute of Public Health of Serbia, which consolidates reporting for the Ministry of Health.[17]
• Assess prevention through hypertension targets, nutrition and lifestyle research, growth and dietary monitoring, disease registers and databases for acute coronary syndrome, interventional cardiology, pacemaker services, rehabilitation and congenital heart disease.[4][5][7][10][11][12][23][15]

Monitoring & Evaluation

The programme combines population surveillance, clinical registers, service databases, screening activity, research and periodic implementation reporting to monitor cardiovascular prevention, treatment and health-system performance. Its most explicit national accountability mechanism requires six-monthly reports to be consolidated by the Institute of Public Health of Serbia and submitted to the Ministry of Health.[17]

• Use baseline mortality, morbidity, hospitalisation, risk-factor and disability-adjusted life-year data, alongside the Serbian Acute Coronary Syndrome Registry, to characterise the cardiovascular disease burden. In 2007, the registry recorded 21,821 new acute coronary syndrome cases and 7,381 deaths.[3][25]
• Develop a national health information system; strengthen research and policy institutions; conduct population research; maintain population cardiovascular disease registers; and adopt provisions on privacy, confidentiality and information security.[18]
• Assess hypertension risk and prevalence, establish standards for monitoring preventive measures, and evaluate preventive procedures during the first year of the national programme.[4]
• Monitor hypertension targets of a 5% reduction in the number of people with hypertension, a 10% increase in newly detected cases through improved diagnosis, and a 10% reduction in complications.[4]
• Track scheduled blood-pressure screening among children aged three to 18 years and adults in primary care, identify people at high risk, and assign a designated coordinating doctor in each health centre.[4][20]
• Assess the health effects of healthy-lifestyle promotion, monitor nutrition quality through a unified methodology, and track children’s growth, development, nutritional status and dietary habits.[7][8]
• Establish a register of people with severe genetically determined hyperlipoproteinaemias by 2015.[5]
• Conduct athlete screening during regular medical examinations and selectively screen first-degree relatives in specified cardiovascular disease families every five years.[21][22]
• Address the absence of a congenital-anomalies registry, as estimates of congenital heart defects are based on tertiary-facility data and known prevalence.[9]
• Maintain and improve databases for patients with USM and the national acute coronary syndrome register. Acute coronary syndrome services were reported to treat about 13,000 patients annually in 54 coronary units or intensive-care departments; pharmacological reperfusion reportedly rose from 25% to more than 50%, while mortality fell from 18% to 8-9%.[10][11]
• Establish a prospective, uniform interventional-cardiology database linked to the Republic Health Insurance Fund to monitor appropriate use of consumable medical materials.[12]
• Use questionnaires, annual reports and prevalence calculations for arrhythmias and sudden-death factors, and maintain a unified electronic pacemaker-services database at the national reference pacemaker centre in the Clinical Centre of Serbia.[23]
• Apply norms for vascular procedures covering consumables, medicines, staffing and operating-theatre time, while using rehabilitation databases, patient information systems and prospective registers to support follow-up, research and assessment of institutional performance.[13][15][16]
• Require primary healthcare centres, relevant health establishments, cardiovascular clinics and hospital departments, and territorial public-health bodies to prepare continuous implementation reports every six months. Have the Institute of Public Health of Serbia aggregate these reports and submit an overall report to the Ministry of Health.[17]

A comprehensive indicator set, evaluation methodology, reporting schedule beyond six-monthly implementation reporting and annual arrhythmia reporting, and sanctions-based accountability arrangements are not specified in the supplied material.[23][13][14][17]

Costing & Financing

Implementation is to be financed from the Republic of Serbia budget through the Ministry of Health allocation, subject to budgetary capacity, and within resources planned in the financial plan of the Republican Health Insurance Fund. No overall programme budget, costed implementation plan, quantified funding gap or economic assumptions are provided.[17]

• Recognise financing and legislation as programme action areas, while noting that no allocations, financing methodology or funding sources are specified for most preventive and service-delivery activities.[2]
• Plan resources for treatment of people with severe genetically determined hyperlipoproteinaemias and for monitoring expected disorders among blood relatives, without a stated monetary amount.[5]
• Provide for screening, health-information systems, registers, staff education, public campaigns, environmental risk control, and preventive interventions, although the source does not quantify their costs or identify dedicated funding.[18][19][4][20]
• Address substantial resource needs for acute and specialist cardiovascular care, including beds, personnel, equipment, catheterisation laboratories, newer thrombolytic medicines, training, additional centres and consumable medical materials.[11][12]
• Apply a five-year amortisation period to existing and newly opened catheterisation laboratories, followed by servicing in accordance with established protocols.[12]
• Support capacity requirements for pacemaker and arrhythmia services, implantable devices, automated external defibrillators, vascular-surgery consumables and medicines, specialised staffing, operating-theatre time, angiologists and expanded cardiac-surgery activity.[23][13][14]
• Note that telemedicine-enabled pacemaker monitoring may reduce patients’ routine-monitoring costs, but no estimated savings, investment requirement or funding arrangement is supplied.[23]
• Expand cardiac-surgery capacity through semi-intensive-care departments, additional theatres, two-shift working and additional staff, and resource rehabilitation, patient databases, research and professional education without monetary estimates.[24][15][16]
• Recognise that treatment and rehabilitation for people with congenital heart defects are characterised as very costly, without a monetary estimate.[9]

The material identifies resource-intensive activities and the broad public financing route, but does not specify expenditure lines, unit costs, allocations by institution, external financing, resource-mobilisation measures, affordability analysis or funding shortfalls.[9][24][15][16][17]